PL357518A1 - Białko chimeryczne, sekwencja, konstrukt, komórkaroślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina, zastosowanie transgenicznej rośliny i chimerycznego białka - Google Patents

Białko chimeryczne, sekwencja, konstrukt, komórkaroślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina, zastosowanie transgenicznej rośliny i chimerycznego białka

Info

Publication number
PL357518A1
PL357518A1 PL35751802A PL35751802A PL357518A1 PL 357518 A1 PL357518 A1 PL 357518A1 PL 35751802 A PL35751802 A PL 35751802A PL 35751802 A PL35751802 A PL 35751802A PL 357518 A1 PL357518 A1 PL 357518A1
Authority
PL
Poland
Prior art keywords
chimeric protein
transgenic plant
sequence
construction
application
Prior art date
Application number
PL35751802A
Other languages
English (en)
Other versions
PL201420B1 (pl
Inventor
Andrzej B. Legocki
Józef Kapusta
Tomasz Pniewski
Olesia Lisowa
Katarzyna Miedzińska
Magdalena Czaplińska
Iwona Femiak
Andrzej Płucienniczak
Małgorzata Kęsik
Anna Porębska
Bogusław Szewczyk
Monika Gut-Winiarska
Jolanta Tyborowska
Jolanta Ficińska
Krystyna Bieńkowska-Szewczyk
Jacek Wojciechowicz
Original Assignee
Instytut Chemii Bioorganicznej Pan
Instytut Biotechnologii i Antybiot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Bioorganicznej Pan, Instytut Biotechnologii i Antybiot filed Critical Instytut Chemii Bioorganicznej Pan
Priority to PL357518A priority Critical patent/PL201420B1/pl
Priority to AU2003287108A priority patent/AU2003287108A1/en
Priority to PCT/PL2003/000136 priority patent/WO2004050692A2/en
Publication of PL357518A1 publication Critical patent/PL357518A1/pl
Publication of PL201420B1 publication Critical patent/PL201420B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL357518A 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina PL201420B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL357518A PL201420B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
AU2003287108A AU2003287108A1 (en) 2002-12-04 2003-12-04 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production
PCT/PL2003/000136 WO2004050692A2 (en) 2002-12-04 2003-12-04 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL357518A PL201420B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Publications (2)

Publication Number Publication Date
PL357518A1 true PL357518A1 (pl) 2004-06-14
PL201420B1 PL201420B1 (pl) 2009-04-30

Family

ID=32464756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357518A PL201420B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Country Status (3)

Country Link
AU (1) AU2003287108A1 (pl)
PL (1) PL201420B1 (pl)
WO (1) WO2004050692A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101014711A (zh) * 2004-06-25 2007-08-08 阿尔特生物科学公司 植物中组织因数的制造
CN109563518A (zh) * 2016-05-12 2019-04-02 巴伊沃爱普有限公司 来自植物的用于经典猪瘟的疫苗组合物及其制造方法
CN107619435B (zh) * 2017-09-19 2021-03-16 中国农业科学院上海兽医研究所 一种猪瘟病毒e2蛋白的抗原表位、抗体的制备及应用
CN109324193A (zh) * 2018-12-07 2019-02-12 中国农业科学院兰州兽医研究所 一种猪瘟病毒抗体的可视化快速检测试剂盒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068994A (en) * 1989-08-07 2000-05-30 Chiron Corporation Ubiquitin expression system
AU1208795A (en) * 1993-11-09 1995-05-29 E.I. Du Pont De Nemours And Company Transgenic fructan accumulating crops and methods for their production
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system
WO2003013598A2 (en) * 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases

Also Published As

Publication number Publication date
WO2004050692A3 (en) 2004-12-09
PL201420B1 (pl) 2009-04-30
AU2003287108A8 (en) 2004-06-23
AU2003287108A1 (en) 2004-06-23
WO2004050692A2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
IL173165A0 (en) Cell cultivation and breeding method
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
IL164113A0 (en) Electode constructs, and related cells and methods
SI1606993T1 (sl) Postopek in naprava za gojenje rastlin
AU2003291628A8 (en) Hiking stick and method of using the same
DK1626979T3 (da) Genetisk modificeret gærart og fremgangsmåder til fermentering, hvor den genetisk modificerede gær anvendes
SG111255A1 (en) Waterproof type lead, method of making waterproof type lead, and jig for making waterproof
GB2427616B (en) Stem cells
AU2003279229A8 (en) Fuel cell assembly and method of making the same
AU2003302701A8 (en) Method of dynamically culturing embryonic stem cells
GB2414480B (en) Directed genetic modifications of human stem cells
AU2003222149A8 (en) High level expression of immunogenic proteins in the plastids of higher plants
EP1702632A4 (en) HAIR GROWTH PROCESS
IL175430A0 (en) Hematopoietic stem cells suitable for transplantation, their preparation and pharmacetical compositions comprising them
IL166467A0 (en) Auto-stimulating cells and method for making and using the same
DE60300681D1 (de) Dedifferenzierte, programmierbare stammzellen monozytären ursprungs, sowie deren herstellung und verwendung
EP1691822A4 (en) HIGH-LEVEL EXPRESSION OF FUSION POLYPEPTIDES IN VEGETABLE SEEDS USING SEED PRESERVATION PROTEINS AS FUSION PROTEIN MEDIA
EP1489163A4 (en) PROCESS FOR INDUCING THE GROWTH OF NERVE STEM CELLS
PL357518A1 (pl) Białko chimeryczne, sekwencja, konstrukt, komórkaroślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina, zastosowanie transgenicznej rośliny i chimerycznego białka
AU2003202392A1 (en) Methods for modifying plant responses to stress and correspondingly derived plants
GB0119497D0 (en) Expression of modified antibodies in avian cells
AU2003225612A8 (en) Expression of hiv-related proteins in plants
AU2003233038A1 (en) Method and device for obtaining plant ingredients
EP1583413A4 (en) PELLET FOR TOLL WEIGHTS, METHOD FOR PELLETIZING AND THIS USING CULTURAL PROCESS FOR PLANTS
EP1563073A4 (en) PROTEIN PRODUCTION METHODS AND MODIFIED CELLS FOR USE IN SUCH METHODS

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20131204